Showing results (211-220 of 355) with videos related to
Sort By:
Pageof 36
Acta Ophthalmologica|October 1, 1994
Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic controlB Sander, M Larsen, C Engler, et al.Diabetes Care|May 1, 1997
White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathyF S Nielsen, P Gaede, P Vedel, et al.The Annals of Otology, Rhinology, and Laryngology|May 1, 1986
Audiological and temporal bone findings in myxedemaA Parving, B Ostri, P Bretlau, et al.Diabetologia|October 1, 1993
The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathyM A Gall, F S Nielsen, U M Smidt, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Renal function and structure in albuminuric type 2 diabetic patients without retinopathyP K Christensen, S Larsen, T Horn, et al.Diabetes Care|December 29, 2000
Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuriaH P Hansen, P H Gaede, B R Jensen, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2005
Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosteroneK J Schjoedt, P Jacobsen, K Rossing, et al.Diabetes|September 1, 1990
Glomerular structure and function in diabetic nephropathy. Early to advanced stagesR Osterby, H H Parving, E Hommel, et al.Diabetologia|October 1, 1985
Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunctionJ Kastrup, T Nørgaard, H H Parving, et al.Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.Pageof 36